Biotech & Pharma.T.A, Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech & Pharma.T.A,

BIB 79.76

-2.1%

Dec 30 4:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Jibacoa who wrote (2650)	1/5/2010 4:30:26 PM
From: Jibacoa	Read Replies (2) of 3722

BCRX did almost close its July 17 UG and has now started to move to the upside.<g> The stock is up 8.3% with volume > 2M close to its ADV. bigcharts.marketwatch.com The pending 4thQ results are still not expected to show a good comparison with previous Yr., but after that things are expected to improve as the EE by Thomson-Reuters is around $0.02 on the black for 2010 vs. the expected loss around $0.80 for the current Yr. Back on Oct 23. BCRX announced that the FDA had issued an emergency use authorization for i.v. peramivir in certain adult and pediatric patients with confirmed or suspected 2009 H1N1 influenza infection who are admitted to a hospital. And on November 5, BCRXt sold 10,000 courses of peramivir at $2,250 each to the U.S. Department of Health and Human services. The price per course is justified when a day in the Intensive Care Unit on a ventilator can cost upwards of $30,000. BCRX will report that $22.5M sale as revenue in the Dec Q. BCRX has been burning its cash at a good clip, but in Nov. it had an offering of 5M shares of its common stock at $9.75 with gross proceeds of $48.75M Woll see how it will handle the resistance above $10 <g> bigcharts.marketwatch.com Bernard

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next